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Abstract 
Background: Both exercise training and diet are recommended to prevent and control 
hypertension (HTN) and overweight/obesity.  
Purpose: To determine the effectiveness of different 16-week aerobic exercise programs with 
hypocaloric diet on blood pressure (BP), body composition, cardiorespiratory fitness (CRF) and 
pharmacological treatment. 
Methods: Overweight/obese, sedentary participants (n=175, 54.08.2 yrs) with HTN, were 
randomized into attention control group (AC, physical activity recommendations) or one of 
three supervised exercise groups [two days/week: high-volume with 45 min of moderate-
intensity continuous training (HV-MICT), HV and high-intensity interval training, alternating high 
and moderate intensities (HV-HIIT), and low volume-HIIT (LV-HIIT, 20 min)]. All variables were 
assessed pre and post intervention. All participants received the same hypocaloric diet. 
Results: Following the intervention, there was a significant reduction in BP and body mass in all 
groups with no between-group differences for BP. However, body mass was significantly less 
reduced in the AC group compared with all exercise groups (AC=-6.6%, HV-MICT=-8.3%, HV-
HIIT=-9.7%, LV-HIIT=-6.9%). HIIT groups had significantly higher CRF than HV-MICT, but there 
were no significant between-HIIT differences (AC=16.4%, HV-MICT=23.6%, HV-HIIT=36.7%, LV-
HIIT=30.5%). Medication was removed in 7.6% and reduced in 37.7% of the participants. 
Conclusions: The combination of hypocaloric diet with supervised aerobic exercise 2 days/week 
offers an optimal non-pharmacological tool in the management of BP, CRF and body 
composition in overweight/obese and sedentary individuals with HTN. HV-HIIT seems to be 
better for reducing body mass compared to LV-HIIT. The exercise-induced improvement in CRF 
is intensity dependent with LV-HIIT as a time-efficient method in this population. 
Trial Registration: NCT02283047 
Keywords: Obesity; hypertension; high-intensity interval training; low-volume training; blood 
pressure; cardiorespiratory fitness; body composition 
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Introduction 
Due to the recent changes in both eating habits and lifestyles (i.e., the abandonment of 
traditional dietary patterns and culinary techniques, increased sedentary time, and decreased 
volume and intensity of physical activity, which results in an imbalance in the energy balance), 
primary hypertension (HTN), overweight/obesity, and being sedentary often coexist in the same 
person.1,2 Obesity has been considered the driving force of this response culminating in a 
significant increase in direct and indirect healthcare costs.3 It is, therefore, important to develop 
cost-effective strategies for the treatment of obesity in order to reduce the prevalence of 
obesity-related HTN.2,4 The European Societies of Hypertension (ESH) and Cardiology (ESC) 
recommend appropriate lifestyles changes for the prevention and treatment of HTN, alongside 
the use of drug therapy in individuals at a high risk.5 One benefit of losing body mass is the 
concomitant reduction in blood pressure (BP),2,3,5 especially in individuals taking 
antihypertensive medication.6 Although individual BP responses to a reduced body mass are 
variable depending on “fat-sensitive” or “fat-resistant” BP,1 it has been demonstrated that 
combining exercise and diet may be the most effective treatment for reducing body mass. 
Consequently, the combination appears to be a logical step in facilitating a substantial 
improvement in cardiometabolic health, including HTN.2,5 
During the last two decades, several studies have shown the effectiveness of adherence 
to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.4,7,8 In a population with 
HTN, the combination of DASH diet with aerobic exercise has resulted in a greater reduction in 
BP and improved cardiovascular biomarkers than DASH diet alone.9 Exercise guidelines 
recommend that both moderate-intensity and high-intensity aerobic training should be used to 
treat and reduce HTN.5 However, there is currently no agreement with respect the optimal 
Frequency, Intensity, Time, and Type (FITT principle) of exercise prescription.10 Previously, 
aerobic high-intensity interval training (HIIT) produced a significant improvement in BP and 
cardiorespiratory fitness (CRF) compared to moderate-intensity continuous training (MICT).11-13 
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Additionally, a dose-response curve for physical activity volume and intensity has previously 
been reported, this is especially important for sedentary individuals and those with moderate 
level of physical condition,14 suggesting that “some is good but more is better.” There is also 
evidence to support the use of low-volume HIIT (LV-HIIT) (i.e., ≤10 min of high-intensity effort) 
vs. high-volume (HV) as a potent and time-efficient training method suggesting “less is more”.15 
Currently, no research has determined the effects of different exercise intensities and 
volumes combined with a hypocaloric diet intervention in overweight/obese, sedentary adults 
diagnosed with HTN. Therefore, the aim of this study was to determine changes in BP, body 
composition, CRF and pharmacological treatment following three different (HV-MICT, HV-HIIT, 
LV-HIIT) 16-week aerobic exercise programs performed twice a week, all combined with 
hypocaloric diet. 
Methods 
Study design 
EXERDIET-HTA study is a multi-arm parallel,  randomized, single-blind controlled experimental 
trial comparing the effects of different 16-weeks aerobic exercise programs (performed two 
days per week) combined with a dietary intervention in sedentary, overweight/obese individuals 
suffering HTN (www.clinicaltrials.gov, number NCT02283047). The study protocol was approved 
by The Ethics Committee of The University of the Basque Country (UPV/EHU, CEISH/279/2014) 
and Clinical Investigation of Araba University Hospital (2015-030), and all participants provided 
written informed consent before any data collection. Medical staff were blinded to the 
participant randomization process. The design, selection criteria, and procedures for the 
EXERDIET-HTA study have been previously detailed.16 
Participants 
One hundred and seventy-five non-Hispanic white participants (n=120 men and n=55 women) 
were enrolled in the study from September 2013 to June 2016 in Vitoria-Gasteiz (Basque 
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Country, Spain). Figure 1 presents a flow diagram of the study process. All participants were 
classified as overweight (body mass index, BMI>25 kg·m-2) or obese (BMI>30 kg·m-2)3 and 
diagnosed with stage 1 or 2 HTN, defined as a systolic blood pressure (SBP) of 140-179 mmHg 
and/or a diastolic blood pressure (DBP) of 90-109 mmHg and/or under antihypertensive 
pharmacological treatment.5 Physical activity behavior was determined by the International 
Physical Activity Questionnaire (IPAQ), and only participants who did not comply with the 
"Global Recommendations on Physical Activity for Health"17 by the World Health Organization 
were selected. 
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Measurements 
The measurements for the study were taken pre (T0) and post (T1) each 16-week intervention 
period.  
Blood Pressure. Ambulatory BP monitoring (ABPM) was conducted over a 24 hour period 
using an oscillometric ABPM 6100 (Welch Allyn, New York City, NY, USA) device to evaluate BP 
in line with the guidelines set by the ESH/ESC.5 Blood pressure (ABPM) values are displayed as 
the mean of the day. 
Cardiorespiratory fitness. A cardiopulmonary exercise test (CPET) was used to determine 
peak oxygen uptake (V̇O2peak) and ventilatory thresholds (VT). The CPET was performed on an 
electronically braked Lode Excalibur Sport Cycle Ergometer (Groningen, The Netherlands). The 
test protocol started at ~70 rpm and 40W, with gradual increments of 10W every minute applied 
until volitional exhaustion occurred. Continuous electrocardiogram monitoring was conducted 
throughout each test. Expired gas analysis was assessed using a commercially available 
metabolic cart (Ergo CardMedi-soft S.S, Belgium Ref. USM001 V1.0). Achievement of V̇O2peak 
criteria has been previously defined.18 Ventilatory thresholds (i.e., VT1 and VT2) were assessed 
by standardized methods using the ventilatory equivalents.18 After completion of the test, 
participants remained stationary on the bike for five minutes recovery with electrocardiogram 
and BP monitoring throughout. The identification of the two VT determined the three different 
exercise intensity domains, or ranges for the exercise intervention design (i.e., R1, light to 
moderate; R2, moderate to high; R3, high to severe).18 
Dietary assessment. Habitual food consumption and nutrient intake were evaluated 
using three questionnaires: dietary history, food frequency questionnaire and two face-to-face 
non-consecutive 24-h recalls. Trained dieticians conducted the necessary correction for within-
subject variability in nutrient intake.19 All nutritional data were calibrated in the Easy Diet 
computer program. Resting energy expenditure was calculated by the Mifflin St Jeor equation, 
7 
 
which has previously been deemed the most appropriate for individuals who are overweight or 
obese.20  
Medication. Prescribed medications were recorded and classified into the groups: 
angiotensin-converting-enzyme inhibitors (ACEI), angiotensin II receptor blockers (ARB), 
diuretics, calcium channel blockers (CCB,) beta-blockers (BB), statins, hypoglycemic agents, 
antiplatelets, and anticoagulants. Medical staff controlled all necessary changes to medication 
pre, during and post-intervention. 
Intervention 
All participants underwent a hypocaloric diet. Following baseline data collection, participants 
were randomly allocated to one of the four intervention groups: the Attention Control (AC) 
group, or the three supervised exercise groups (HV-MICT, HV-HIIT, or LV-HIIT). Each group was 
stratified by gender, SBP, BMI, and age. All participants were asked to continue with their normal 
physical activity patterns outside of the study protocol. However, in addition to treatment for 
the hypocaloric diet, the AC received the standard guidelines for physical activity 
recommendations in order to comply with ethical procedures regarding health.5 
Intervention procedures. All exercise groups trained for two nonconsecutive days per 
week under the supervision of exercise specialists. All sessions started and finished with BP 
monitoring, and training intensity was dictated by individual heart rate (HR) responses (Polar 
Electro, Kempele, Finland) and rate of perceived exertion (Borg’s 6-20 point). Each session 
included a 5-10 min warm-up and a 10 min cool-down. The core part of each training session 
consisted of a range of aerobic exercises; i.e., one day of the week on the treadmill, and the 
second one on the bike (BH Fitness equipmentTM). The HV-MICT group performed 45 min aerobic 
exercise, whereas the HV-HIIT and LV-HIIT conducted 45 and 20 min, respectively. The intensity 
was individually tailored to each participant’s HR at moderate (R2) or vigorous intensities (R3), 
adjusting the speed and/or incline of the treadmill or the power and speed on the exercise-bike. 
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The rationale of mixing stationary exercise-bike and treadmill was to avoid the osteoarticular 
impact of two treadmill days taking into account the nature of the HIIT program and the impact 
derived from overweight/obese participants. The HV-MICT group performed 45 min continuous 
steady training at R2. Supervised exercise-training protocols have been previously explained in 
full.16 
Considering the average V̇O2peak at baseline for all participants (2.010.5 L·min-1), the 
total work performed by the three exercise groups was calculated using the V̇O2-time 
relationship. As such, the moderate intensity at R2 was taken as 65% of V̇O2peak (1.3 L·min-1) and 
the high intensity at R3 as 90% of V̇O2peak (1.8 L·min-1). Thus, the HV-MICT performed 45 min at 
R2 twice per week representing ~117 L. The HV-HIIT performed 45 min twice per week, one day 
on the treadmill (4x4 min at 1.8 L·min-1 at R3 and 29 min at 1.3 L·min-1 at R2, representing ~66.5 
L), and one day on the exercise-bike (18x30 s at R3 and 36 min at R2 representing ~63 L·min-1 
resulting a total work of ~129.5 L). The LV-HIIT group performed 20 min twice per week, 
exercising one day on the treadmill (2x4 min at R3 and 12 min at R2 representing ~30 L) and one 
day on the exercise-bike (9x30 s at R3 and 15:30 min at R2 representing ~28 L resulting a total 
work of ~58 L). A criterion for completing the study was set at 100%. Thus, all participants in the 
supervised-exercise groups performed 32 sessions; if a session was missed (a maximum of four 
were allowed), these were added on to the end of the 16-week program, maintaining the two 
sessions per week. 
Diet intervention. Hypocaloric and controlled sodium diet (3-6 g/d) was prescribed for 
each participant. The diet was designed to provide 25% less energy than their daily energy 
expenditure and to achieve a weekly loss in body mass of between 0.5 and 1.0 kg in accordance 
with the recommendations of the American Diabetes Association and the Spanish Society for 
the Study of Obesity.21 The diet contained 30% fat, 15% protein, and 55% carbohydrates and 
was designed in accordance with the DASH diet.7 Every two weeks participants were weighed 
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and received encouragement and advice alongside nutritional counseling in order to aid 
compliance.  
Statistical analysis 
Descriptive statistics were calculated for all variables. Data are expressed as mean±standard 
deviations (SD) and the range. All variables that were not normally distributed using a 
Kolmogorov-Smirnov test and so they were log transformed prior to any analysis. Analysis of 
variance (ANOVA) was used to determine if there were significant pre-intervention between-
group differences. The comparison of frequencies in categorical variables among groups was 
performed using Chi-Square test. A 2 sample t-test was used to determine whether there was a 
significant difference in the recorded data between pre and post intervention within each group. 
Analysis of covariance (ANCOVA) was used to examine the delta (Δ) score for each group (AC, 
HV-MICT, HV-HIIT, LV-HIIT), adjusting  for age, sex, changes in body mass and the initial value of 
each of the dependent variables. Helmert contrasts were performed to analyse the difference 
between the three exercise groups pooled together and AC group. Bonferroni correction was 
used to determine the level of significance when a significant main effect was found. Data were 
analyzed according to the intention-to-treat principle. Statistical significance was set at P<0.05. 
All statistical analyses were performed with the SPSS version 22.0. Power calculation was 
completed using G*Power 3 analysis program.22 The required sample size was determined for 
the primary outcome variable (SBP). It was identified that adequate power (0.80) to evaluate 
differences in our design consisting of four experimental groups would be achieved with 164 
people (41 each group, α=0.05, effect size f=0.27) based on the pilot study with an SD of 9 
mmHg. 
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Results 
Baseline characteristics. Participants and medications were classified by groups and presented 
in Table 1. Baseline data for all participants have been previously published.23 At baseline, 86.9% 
of participants were taking medication irrespective of group. The percentage of participants who 
took one, two, three or >four medications were 40%, 26.3%, 13.1% and 7.4%, respectively. With 
respect to medication type, 32.3% of participants took ACEI, 41.1% ARB, 34.3% diuretics, 15.4% 
CCB, 9.8% BB, 13.7% statins, 6.3% hypoglucemic, 4.6% antiplatelets, and 1.1% anticoagulants. 
There were no significant between-group differences observed for anthropometric, body 
composition, hemodynamic, cardiorespiratory and pharmacological treatment at baseline. No 
major complications or cardiac events occurred during any part of the study.  
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Table 1. Physical, physiological and pharmacological therapy characteristics at baseline for each 
group of participants (N=175). Values are meanSD, percent (%) or number. 
 AC 
(N=45) 
HV-MICT 
(N=42) 
HV-HIIT  
(N=44) 
LV-HIIT 
(N=44) 
P 
Sex (men/women) 30/15 28/14 32/12 30/14 0.9 
Age (yrs) 53.1±8.3 54.7±7.6 53.5±9.1 54.7± 8.8 0.7 
Body mass (kg) 91.2±15.9 93.4±16.4 90.3±15.6 91.6±14.6 0.8 
BMI (kg m-2) 31.9±4.6 32.2±4.4 31.2±3.6 32.0±4.6 0.7 
Waist (cm) 103.1±11.6 105.5±12.6 102.0±11.0 103.5±10.4 0.6 
Hip (cm) 107.5±9.7 108.8±9.4 106.2±7.6 108.9±10.7 0.5 
Waist/hip ratio 0.96±0.7 0.97±0.1 0.96±0.8 0.96±0.1 0.8 
FFM (%) 66.2±8.1 64.6±8.6 67.7±6.3 67.0±8.1 0.3 
FBM (%) 33.7±8.1 35.4±8.6 32.3±6.4 32.9 ±8.1 0.3 
FFM/FBM 2.14±0.8 1.98±0.7 2.2±0.6 2.18 ±0.7 0.5 
Rest SBP (mmHg) 139±13 133±12 133±10 135±13 0.06 
Rest DBP (mmHg) 79±8 76±8 79±7 77±9 0.1 
Rest HR (beats·min-1) 69±10 74±9 70±11 69±10 0.08 
Rest MBP (mmHg) 99±9 94±8 97±7 97±10 0.1 
V̇O2peak (L min-1) 2.04±0.59 2.01±0.55 2.0±0.5 2.01±0.5 0.9 
V̇O2peak (mL kg.1 min-1) 22.5±6.0 21.6±5.2 22.4±4.8 22.0±5.6 0.9 
VT1 (mL kg-1 min-1) 13.1±5.8 12.2±3.9 12.7±4.6 12.7±4.4 0.8 
VT2 (mL kg-1 min-1) 17.1±6.6 17.7±5.6 17.9±6.5 17.8±6.4 0.9 
MET 6.4 ±1.7 6.13±1.4 6.4±1.4 6.3±1.6 0.8 
Medication (%) 84 93 82 89 0.6 
ACEI (%) 37.8 45.3 40.9 29.5 0.5 
ARB (%) 46.7 40.5 27.3 50.0 0.1 
Diuretics (%) 33.3 38.1 34.1 31.8 0.9 
CCB (%) 8.9 21.4 13.7 18.2 0.4 
BB (%) 13.3 11.9 9.1 4.5 0.5 
Statins (%) 11.1 16.7 16.0 11.4 0.8 
Hypoglycemic (%) 6.7 2.4 2.3 13.6 0.09 
Antiplatelets+anticoagulants (%) 4.4 9.5 2.3 2.3 0.3 
Cigarette smoking (%) 2.2 9.8 20.9 9.3 0.08 
DM (%) 4.4 4.9 7.0 11.6 0.5 
BMI, body mass index; FFM, fat free mass; FBM, fat body mass; SBP, systolic blood pressure; DBP diastolic blood 
pressure; HR, heart rate; MBP, mean blood pressure; V̇O2peak, peak oxygen uptake; VT, ventilatory threshold; 
MET, metabolic equivalent of task; ACEI, angiotensin-converting-enzyme inhibitors; ARB, angiotensin II 
receptor blockers; CCB, calcium channel blockers; BB, beta blockers; DM, diabetes mellitus. BP values show the 
mean BP calculated by 24 hours ambulatory blood pressure monitoring. P<0.05. AC, attention control group; 
HV-MICT, high-volume and moderate-intensity continuous training group; HV-HIIT, high-volume high-intensity 
training group; LV-HIIT, low-volume high-intensity training group. 
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Physiological changes (Table 2). Following the 16-week intervention, resting SBP, DBP, 
mean BP and HR decreased (P<0.05). Further, in all groups, CRF expressed as V̇O2peak (L min-1) 
(AC, =10%; P<0.05; HV-MICT, =15%; HV-HIIT, =25%; and LV-HIIT, =25%; P<0.001), V̇O2peak 
(mL kg-1 min-1) and METs (P<0.001) increased. All groups increased at least one MET (Table 2 and 
Figure 2). However, at VT1 and VT2 (mL kg-1 min-1) improvements were observed in HV-HIIT for 
VT1 (P=0.003) and both HIIT exercise groups for VT2 (HV-HIIT, P<0.001 and LV-HIIT, P=0.016). In 
contrast, no significant changes were seen in the AC and HV-MICT groups for either VT1 or VT2. 
Following Bonferroni correction, there were no significant between group differences in any 
hemodynamic variables (i.e., BP and HR) (Table 2). However, AC showed a smaller but significant 
improvement in V̇O2peak (P<0.001) compared with all exercise groups (HV-MICT, mean 
difference=0.606, 95% CI=-2.193-3.405 mL kg-1 min-1; HV-HIIT, mean difference=3.215, 95% 
CI=0.418-6.012 mL kg-1 min-1; and LV-HIIT, mean difference=2.846, 95% CI=0.082-5.610 mL kg-1 
min-1) and MET (P<0.001). Furthermore, both HIIT groups, showed a greater (P=0.008) V̇O2peak 
and MET (P=0.018) than HV-MICT. In contrast, there were no significant between group 
differences in any VT variables. 
Figure 2. Peak Metabolic Equivalent of Task (MET) differences after 16-week 
intervention period for each group.  
 
Horizontal line indicates a minimal of 1 MET increase.*P-value<0.05 from the AC. & P-
value<0.05 from the HV-MICT 
0
0.5
1
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2
2.5
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Anthropometric and body composition (Table 2). Following 16-weeks intervention body 
mass, BMI, waist and hip circumferences, waist-to-hip ratio (WHR), and fat body mass (FBM) 
decreased (P<0.05) in all groups. In addition, fat-free mass (FFM) and FFM/FBM ratio increased 
(P<0.05). Following Bonferroni correction, there were significant between-group differences in 
anthropometric and body composition. The AC had a smaller body mass reduction (T0 vs. T1 
difference%, =-6.6%; P=0.029) and change in BMI (=6.7%; P=0.030) compared to those in all 
exercise groups: HV-MICT (=-8.3%), HV-HIIT (=-9.7%) and LV-HIIT (=-6.9%). Further, HV-HIIT 
had a greater reduction in body mass (P=0.011, mean difference=2.436, 95% CI=-4.972-0.099 
kg) and BMI (P=0.015, mean difference=0.805, 95% CI=-0.066-1.675 kg·m-2) compared with LV-
HIIT. However, there were no significant between-group differences observed for WHR. With 
respect to body composition, there were no significant differences in %FFM between AC and all 
exercise groups (=4.0%; P=0.062): HV-MICT (=6.2%), HV-HIIT (=6.8%) and LV-HIIT (=4.6%). 
However, the %FFM gain in the HV-HIIT was greater than the AC (P=0.039) group. Similarly, there 
were no significant differences in %FBM when exercise groups were compared together with AC 
(=-8.1%; P=0.062): HV-MICT (=-11.3%), HV-HIIT (=-14.1%) and LV-HIIT (=-9.6%). However, 
HV-HIIT resulted in a greater reduction of %FBM than the AC group (P=0.038). 
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Table 2. Physiological data and body composition for all groups before and after intervention period. Mean±SD 
 
 AC 
(N=40) 
HV-MICT 
(N=40) 
HV-HIIT 
(N=42) 
LV-HIIT 
(N=41) 
P 
AC vs. EG 
P 
Intergroups 
F-value %Variance 
Rest SBP (mmHg)         
T0 140.0±13.2 132.7±12.7 131.7±10.4 135.6±13.2     
T1 133.0±15.3* 125.4±8.9* 127.1±9.7* 127.1±10.5* 0.897 0.418 1.611 1.9 
Rest DBP (mmHg)         
T0 79.9±7.2 75.4±8.0 79.0±6.9 78.2±8.2     
T1 75.1±9.1* 72.0±6.7* 74.1±6.2* 73.9±7.4* 0.544 0.762 0.050 0.8 
Rest HR (beats·min-1)         
T0 68.9±9.9 73.6±9.2 70.5±11.0 69.2±10.5     
T1 65.2±9.2* 68.1±8.1* 63.7±8.8* 64.4±10.0* 0.747 0.485 0.819 1.7 
Rest MBP (mmHg)         
T0 99.9±8.4 94.5±8.5 96.6±7.2 97.3±9.1     
T1 94.4±10.4* 89.8±6.2* 91.8.4±6.9* 91.6±7.6* 0.694 0.808 0.567 0.7 
V̇O2peak  (L min-1)         
T0 2.0±0.6 2.0±0.6 2.0±0.4 2.0±0.5     
T1 2.2±0.7* 2.3±0.7*x 2.5±0.7*x$ 2.5±0.6*x$ 0.001 0.001 5.329 9.8 
V̇O2peak  (mL kg-1 min-1)         
T0 22.6±6.1 21.6±5.2 22.4±4.9 22.3±5.2     
T1 26.3±8.3* 26.7±7.4*x 30.6±8.5*x$ 29.1±6.7*x$ 0.009 0.003 4.828 8.6 
MET         
T0 6.4±1.7 6.1±1.5 6.4±1.4 6.4±1.5     
T1 7.5±2.4* 7.6±2.1*x 8.7±2.4*x$ 8.3±1.9*x$ 0.011 0.007 4.209 7.6 
VT1 (mL kg-1 min-1)         
T0 13.1±5.8 12.2±3.9 12.7±4.6 12.7±4.4     
T1 13.3±7.2 12.9±5.8 15.7±6.8* 14.2±7.0 0.754 0.238 1.4 2.7 
VT2 (mL kg-1 min-1)         
T0 17.1±6.6 17.7±5.6 17.9±6.5 17.8±6.4     
T1 19.5±10.2 19.7±8.6 24.5±9.6* 21.6±10.3* 0.843 0.057 2.6 4.7 
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Body mass (kg)         
T0 89.5±14.8 94.0±16.6 90.5±15.7 91.2±14.6     
T1 83.6±14.9* 86.2±15.8*x 81.7±14.0*x 84.9±13.6*x‡ 0.029 0.010 3.909 6.9 
BMI (kg m-2)         
T0 31.2±3.9 32.4±4.4 31.2±3.6 31.6±4.3     
T1 29.1±4.1* 29.7±4.1*x 28.2±3.4*x 29.4±4.1*x‡ 0.030 0.012 3.846 6.7 
Waist (cm)         
T0 102.2±11.3 105.1±11.7 102.1±11.1 102.8±10.0     
T1 96.2±11.3* 97.6±10.5* 93.8±11.4* 96.2±8.7* 0.146 0.279 1.480 2.4 
Hip (cm)         
T0 107.0±8.8 108.8±9.1 106.2±7.7 107.3±8.2     
T1 103.4±8.9* 103.9±9.1* 102.6±7.2* 103.4±7.2* 0.456 0.510 0.440 1.5 
Waist/hip ratio         
T0 0.96±0.08 0.97±0.09 0.96±0.08 0.96±0.09     
T1 0.93±0.08* 0.94±0.08* 0.91±0.08* 0.93±0.07* 0.461 0.188 1.388 3.1 
FFM (%)         
T0 66.8±7.9 64.6±8.6 67.5±6.4 67.7±7.0     
T1 69.5±8.2* 68.6±8.4* 72.1±7.0*x 70.8±8.1* 0.062 0.035 2.935 5.3 
FBM (%)         
T0 33.2±7.9 35.4±8.6 32.5±6.4 32.3±7.7     
T1 30.5±8.2* 31.4±8.3* 27.9±7.0*x 29.2±8.1* 0.062 0.034 2.959 5.4 
FFM/FBM         
T0 2.1±0.8 2.0±0.7 2.2±0.6 2.2±0.7     
T1 2.5±1.0* 2.4±0.9* 2.8±0.9* 2.6±1.0* 0.061 0.067 2.439 4.5 
SBP, systolic blood pressure; DBP, diastolic blood pressure, HR, heart rate; MBP, mean blood pressure; V̇O2peak, peak oxygen uptake; 
MET, metabolic equivalent; VT, ventilatory threshold; BMI, body mass index; FFM, fat free mass; FBM, fat body mass; AC, attention 
control group; HV-MICT, high-volume and moderate-intensity continuous training group; HV-HIIT, high-volume and high-intensity 
training group; LV-HIIT, low-volume and high-intensity training group; EG, exercise groups. BP values show the mean BP calculated by 
24 hours ambulatory blood pressure monitoring. *P-value<0.05 from T0. xP-value<0.05 from the AC. $P-value<0.05 from the HV-MICT. 
‡P-value<0.05 from the HV-HIIT. 
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Pharmacological therapy. Following the 16-week intervention, medication was reduced 
from 86.9% to 79.3%. Further, 37.7% of participants, which still took medication, had their dose 
reduced. The percentage of participants who took one, two, three or more than four 
medications was also reduced to 35.4%, 29.9%, 8.5% and 5.4%, respectively. Specifically, 32.3% 
of participants took ACEI, 39 % ARB, 30.5% diuretics, 15.2% CCB, 6.1% BB, 11.0% statins, 6.7% 
hypoglucemic, 3.7% antiplatelets, and 1.2% anticoagulants. Chi-square test revealed that there 
were no significant between-group differences in medication reduction. 
Discussion 
To our knowledge, this is the first known study to investigate the impact of exercise 
programmes, which use different intensities and volumes in conjunction with a dietary 
intervention in overweight/obese, sedentary adults diagnosed with HTN. The main findings of 
the study were: 1) all groups significantly improved BP, CRF, body composition following 16-
weeks intervention; 2) a substantial decrease of pharmacological treatment was observed; 3) 
hypocaloric diet and two days of supervised exercise showed improved body mass and CRF 
compared to a diet only intervention (AC group), but no significant between group differences 
were observed in BP; 4) the HV-HIIT exercise elicited a greater improvement in body mass and 
body composition than the LV-HIIT exercise, and 5) the exercise-induced improvement in CRF is 
more dependent on intensity than volume. 
In this study, a 16-week lifestyle intervention significantly improved cardiovascular risk 
factors (i.e., BP, CRF, and adiposity) in all groups and pharmacological therapy was largely 
reduced or removed completely. Hence, the hypocaloric DASH diet along with both supervised 
aerobic exercise and no supervised physical activity recommendations could offer an optimal 
non-pharmacological tool in the management of HTN. As such, this could result in a cost-
effective model for cardiovascular disease prevention8 and healthcare cost reduction. These 
results corroborate those of previous investigations that suggested overweight/obese people 
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with above-normal BP could improve BP, and body mass, vascular and autonomic function when 
they combine exercise and DASH diet with calorie restriction.9,24 Further, we provide evidence 
that the combined effects of physical activity and hypocaloric diet enhance BP and reduce the 
need for pharmacological therapy.25 To this end, contrary to our hypothesis, all supervised 
exercise groups had a reduced BP similar to the AC group post intervention (7-9 mmHg in SBP 
and 3-5 mmHg in DBP). As such, the potential of the DASH diet to elicit significant improvements 
in SBP and DBP in individuals with HTN who are overweight/obese is confirmed,8 and it appears 
to be independent of the FITT principle. However, the lack of between-group differences in BP 
in the current study could in part be explained by 1) the role physical activity plays in augmenting 
baroreflex dysfunction, which may result in a reduced sympathetic outflow with a lowered BP 
and HR response,26,27 2) the different exercise interventions appear to be medication dependent 
with similar BP reduction following all exercise intensities (i.e., MICT or HIIT);11 and 3) two days 
of supervised exercise may not be enough to differentiate between exercise modalities over the 
16-week period. Previously, it has been reported that there is greater antihypertensive effect 
seen in response to high-intensity exercise when compared to lower exercise intensities.11 
Previous research found that HIIT three times a week elicited greater significant reductions in 
BP than MICT and a control group following a 12-week intervention.12 However, it should be 
noted that participants using the antihypertensive drug in the mentioned study performed a 
wash-out before inclusion and so a greater effect may have been seen. 
To achieve a negative energy balance is to challenge and target specific pathways in 
order to produce beneficial changes in the pathogenesis of obesity-related HTN.2 In the present 
study, despite the antihypertensive medication and the metabolic potential side effects,1,4 a dual 
treatment of hypocaloric diet combined with supervised exercise twice a week was the optimal 
way to reduce body mass compared to AC. More specifically, HV-HIIT significantly enhanced 
body mass reduction (kg, ↓9.7%), and fat distribution the most (%FFM=↑6.8 and 
%FBM=↓14.1). Given that, HV-MICT and LV-HIIT exercise programs were performed with the 
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same frequency but a reduced intensity and volume, respectively, the improvements seen in 
HV-HIIT compared to the other two exercise programs were likely caused by enhanced energy 
expenditure. These data suggest that sedentary people with overweight/obesity and HTN can 
adapt and respond to exercise training during an energy deficit program with a dose-response 
curve related to volume and intensity. Furthermore, it has been shown that high levels of 
moderate-to-vigorous-intensity physical activity are associated with long-term body mass loss 
maintenance,28 despite the probable adaptive metabolic response caused by the compensatory 
down-regulation in resting energy expenditure following exercise-induced body mass loss.29 
Cardiorespiratory fitness is an independent predictor of all-cause and disease-specific 
mortality in various populations irrespective of BMI.30 Thereby; the fat-but-fit paradigm has 
been given much attention with respect to reducing the risk of illness and death.31,32 Thus, in the 
present study (Table 1), while all participants were overweight/obese and considered unfit at 
baseline with CRF classified as poor (<24.4 mL kg-1 min-1 in men and <19 mL kg-1 min-1 in 
women),23,33 following the 16-week intervention CRF was improved and classified as “fair-
good”.33 Further, all groups improved by at least 1 MET (Figure 2) during the course of the 
intervention. As such, although participants were still classified as overweight their CRF 
increased by 16-36%, which is associated with a considerable improvement in cardiovascular 
risk and reduced all-cause mortality.34 In addition, the magnitude of change in CRF improvement 
was significantly different between exercise groups. Specifically, both HIIT programmes elicited 
significantly greater improvements in CRF than the HV-MICT and AC (Table 2 and Figure 2) 
groups. Additionally, HIIT groups showed significant improvements in submaximal variables such 
as VT (Table 2). These enhanced improvements in CRF may be due to stress adaptations, which 
have been previously shown to cause notable cellular, vascular and metabolic adaptations 
during HIIT.35 One remarkable finding of the present study was that HIIT improved CRF 
irrespective of the training volume (LV vs. HV). Our findings reinforce previous studies, which 
suggest LV-HIIT is a time-efficient and effective protocol in clinical populations answering the 
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question “Can less be more?36,37 As such, it may be that LV-HIIT is more appealing for individuals 
who do not have enough time to train for long periods, or for those who have medical conditions 
which prevent them from performing exercise for prolonged periods of time.13,35 However, 
taking into account the urgent need of increasing caloric expenditure and CRF in this population, 
LV-HIIT could be an option to tailor supervised exercise along with daily recommendations of 
lower intensities physical activities.38 
Although the current study has provided clear evidence for the benefits of combining a 
hypocaloric DASH diet with exercise, there are some limitations which should be considered: 1) 
though every effort was made to manage unsupervised time, physical activity performed by 
participants in AC could not be controlled, and 2) it is difficult to regulate and monitor the 
adherence of participants to the diet.  
Conclusions 
In summary, the present study has shown that the combination of hypocaloric DASH diet with 
different supervised aerobic exercise programs twice a week offers an optimal non-
pharmacological tool in the management of risk factors in sedentary individuals with 
overweight/obesity and HTN. Benefits include an enhanced control of BP, body mass 
composition, CRF and pharmacological treatment. A dose-response curve related to volume and 
intensity in the form of 2-weekly bouts of HV-HIIT provided significantly greater reductions in 
body mass compared to LV. However, the key to enhancing CRF in this population appears to be 
linked with exercise intensity irrespective of duration. As such, LV-HIIT may be a time-efficient 
and effective method of improving health. 
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